331 related articles for article (PubMed ID: 22527424)
21. Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis.
Kose O; Koc E; Erbil AH; Caliskan E; Kurumlu Z
J Dermatolog Treat; 2008; 19(3):159-63. PubMed ID: 18569272
[TBL] [Abstract][Full Text] [Related]
22. Open-label study to assess the safety and efficacy of imiquimod 5% cream applied once daily three times per week in cycles for treatment of actinic keratoses on the head.
Rivers JK; Rosoph L; Provost N; Bissonnette R
J Cutan Med Surg; 2008; 12(3):97-101. PubMed ID: 18544290
[TBL] [Abstract][Full Text] [Related]
23. Results of an investigator-initiated single-blind split-face comparison of photodynamic therapy and 5% imiquimod cream for the treatment of actinic keratoses.
Hadley J; Tristani-Firouzi P; Hull C; Florell S; Cotter M; Hadley M
Dermatol Surg; 2012 May; 38(5):722-7. PubMed ID: 22340282
[TBL] [Abstract][Full Text] [Related]
24. A comparison of cryotherapy and imiquimod for treatment of actinic keratoses: lesion clearance, safety, and skin quality outcomes.
Foley P; Merlin K; Cumming S; Campbell J; Crouch R; Harrison S; Cahill J
J Drugs Dermatol; 2011 Dec; 10(12):1432-8. PubMed ID: 22134568
[TBL] [Abstract][Full Text] [Related]
25. Comparison of topical 3% diclofenac sodium gel and 5% imiquimod cream for the treatment of actinic keratoses.
Akarsu S; Aktan S; Atahan A; Koç P; Özkan S
Clin Exp Dermatol; 2011 Jul; 36(5):479-84. PubMed ID: 21418281
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies.
Gupta AK; Davey V; Mcphail H
J Cutan Med Surg; 2005 Oct; 9(5):209-14. PubMed ID: 16502198
[TBL] [Abstract][Full Text] [Related]
27. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.
Sotiriou E; Apalla Z; Maliamani F; Zaparas N; Panagiotidou D; Ioannides D
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1061-5. PubMed ID: 19470041
[TBL] [Abstract][Full Text] [Related]
28. Imiquimod 5% cream for actinic keratosis.
Perras C
Issues Emerg Health Technol; 2004 Sep; (61):1-4. PubMed ID: 15382379
[TBL] [Abstract][Full Text] [Related]
29. Topical Imiquimod in the Treatment of Conjunctival Actinic Keratosis.
Rowlands MA; Giacometti JN; Servat J; Materin MA; Levin F
Ophthalmic Plast Reconstr Surg; 2017; 33(1):e21-e23. PubMed ID: 25853505
[TBL] [Abstract][Full Text] [Related]
30. Visualization and treatment of subclinical actinic keratoses with topical imiquimod 5% cream: an observational study.
Kopera D; Kerl H
Biomed Res Int; 2014; 2014():135916. PubMed ID: 24900953
[TBL] [Abstract][Full Text] [Related]
31. Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series.
Tambone S; Fargnoli MC; Capizzi R; Peris K
G Ital Dermatol Venereol; 2018 Jun; 153(3):333-337. PubMed ID: 26439591
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms.
Harrison LI; Skinner SL; Marbury TC; Owens ML; Kurup S; McKane S; Greene RJ
Arch Dermatol Res; 2004 Jun; 296(1):6-11. PubMed ID: 15083310
[TBL] [Abstract][Full Text] [Related]
33. Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis.
Persaud AN; Shamuelova E; Sherer D; Lou W; Singer G; Cervera C; Lamba S; Lebwohl MG
J Am Acad Dermatol; 2002 Oct; 47(4):553-6. PubMed ID: 12271300
[TBL] [Abstract][Full Text] [Related]
34. Lmax and imiquimod 3.75% in daily clinical practice.
Gupta G
J Eur Acad Dermatol Venereol; 2015 Jan; 29 Suppl 1():15-8. PubMed ID: 25470720
[TBL] [Abstract][Full Text] [Related]
35. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials.
Korman N; Moy R; Ling M; Matheson R; Smith S; McKane S; Lee JH
Arch Dermatol; 2005 Apr; 141(4):467-73. PubMed ID: 15837864
[TBL] [Abstract][Full Text] [Related]
36. Development of subacute cutaneous lupus erythematosus associated with the use of imiquimod to treat actinic keratoses.
Burnett TJ; English JC; Ferris LK
J Drugs Dermatol; 2010 Aug; 9(8):1022-4. PubMed ID: 20684157
[TBL] [Abstract][Full Text] [Related]
37. Placebo-controlled, double-blind, randomized pilot study of imiquimod 5% cream applied once per week for 6 months for the treatment of actinic keratoses.
Zeichner JA; Stern DW; Uliasz A; Itenberg S; Lebwohl M
J Am Acad Dermatol; 2009 Jan; 60(1):59-62. PubMed ID: 18937999
[TBL] [Abstract][Full Text] [Related]
38. A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses.
Jorizzo JL; Markowitz O; Lebwohl MG; Bourcier M; Kulp J; Meng TC; Levy S
J Drugs Dermatol; 2010 Sep; 9(9):1101-8. PubMed ID: 20865842
[TBL] [Abstract][Full Text] [Related]
39. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses.
Stockfleth E; Meyer T; Benninghoff B; Salasche S; Papadopoulos L; Ulrich C; Christophers E
Arch Dermatol; 2002 Nov; 138(11):1498-502. PubMed ID: 12437457
[TBL] [Abstract][Full Text] [Related]
40. Complete clearance is sustained for at least 12 months after treatment of actinic keratoses of the face or balding scalp via daily dosing with imiquimod 3.75% or 2.5% cream.
Hanke CW; Swanson N; Bruce S; Berman B; Kulp J; Levy S
J Drugs Dermatol; 2011 Feb; 10(2):165-70. PubMed ID: 21283921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
